Literature DB >> 25825577

Megaloblastic anemia presenting with massive reversible splenomegaly.

Vineet Behera1, Makarand Randive1, Praveen Sharma1, Velu Nair1.   

Abstract

Megaloblastic anemia (MA) is a common disorder with varied manifestations. It generally results in mild to moderate splenomegaly which is due to sequestration of macrocytic erythrocytes in spleen. Massive splenomegaly is generally seen in infections, myeloproliferative diseases, neoplasms, storage disorders or hematological conditions; but is not heard of and has rarely been reported in MA. We discuss a case of massive splenomegaly who presented with symptomatic anemia and was found to have MA. He was extensive evaluated for all other causes of massive splenomegaly which was normal. Further, after a therapeutic trial of MA he showed a regression in spleen size confirming that the massive splenomegaly was attributable to MA.

Entities:  

Keywords:  Massive splenomegaly; Megaloblastic anemia; Splenomegaly

Year:  2014        PMID: 25825577      PMCID: PMC4375152          DOI: 10.1007/s12288-014-0461-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

1.  Hyperhomocysteinaemia, thrombosis and pernicious anaemia.

Authors:  Nicolas Limal; Karine Scheuermaier; Zoubida Tazi; Damien Sene; Jean-Charles Piette; Patrice Cacoub
Journal:  Thromb Haemost       Date:  2006-08       Impact factor: 5.249

2.  [Portal and mesenteric vein thrombosis associated with hyperhomocysteinemia and pernicious anemia in a patient heterozygous for the MTHFR C677T mutation].

Authors:  Mario Fernández-Ruiz; Félix Alonso-Navas; Eva Muro; Mercedes Pérez-Carreras
Journal:  Med Clin (Barc)       Date:  2010-03-06       Impact factor: 1.725

3.  Reversible marked splenomegaly in pernicious anemia.

Authors:  R K Pruthi; A Tefferi; R M Petitt
Journal:  Ann Intern Med       Date:  1993-11-15       Impact factor: 25.391

4.  [A case of pernicious anemia with giant splenomegaly (author's transl)].

Authors:  H Enokihara; K Saito; S Hazama; K Hirose; H Komatsu; S Furusawa; H Shishido; T Nakajima
Journal:  Rinsho Ketsueki       Date:  1978-12

5.  Splenomegaly in 2,505 patients in a large university medical center from 1913 to 1995. 1913 to 1962: 2,056 patients.

Authors:  R A O'Reilly
Journal:  West J Med       Date:  1998-08

6.  Effects of cyanocobalamin on immunity in patients with pernicious anemia.

Authors:  Mehmet Ali Erkurt; Ismet Aydogdu; Mustafa Dikilitaş; Irfan Kuku; Emin Kaya; Nihayet Bayraktar; Onur Ozhan; Ibrahim Ozkan; Ahmet Sonmez
Journal:  Med Princ Pract       Date:  2008-02-19       Impact factor: 1.927

  6 in total
  2 in total

1.  An Unusual Presentation of Vitamin B12 Deficiency Associated With Massive Splenomegaly, Hemolytic Anemia, and Pancytopenia: A Case Report.

Authors:  Hisham Elhiday; Muzamil Musa; Syed Ahmed Hussaini; Akram Al-Warqi; Gamal Alfitori
Journal:  Cureus       Date:  2022-06-18

2.  Splenomegaly in a Patient with a History of Pernicious Anemia; the Potential Therapeutic Effects of B12 Therapy.

Authors:  Alexis Lordi; Nida Ansari; Michael Maroules; Anusha Manjegowda
Journal:  Case Rep Hematol       Date:  2022-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.